photo walkheader_zpsd5bunpmi.png

Salivary Biomarkers for Detection of Pancreatic Cancer

A long friend to the mission of our foundation, Al Laporta, DDS of New Your (who lost his beloved mother to pancreatic cancer) reminds us of intriguing work by physician and dentist researchers at UCLA demonstrating proof of concept work published in 2010 in the journal Gastroenterology which identified 12 salivary messenger RNA biomarkers that gave a high specificity (95%) and sensitivity (90%) for the diagnosis of pancreatic cancer (ductal adenocarcinoma of the pancreas).

A diagnostic test based on this work would be noninvasive.


More here


Dale O’Brien, MD